diabetes news, novo nordisk insulin fiasp

NEWS

HBA1C SURVEY REQUEST

RAPID RESULTS

A new, fast-acting mealtime insulin for

adults living with Type 1 or Type 2 diabetes

has been launched in the UK by Novo

Nordisk. Fiasp (fast-acting insulin aspart,

more commonly known as NovoRapid)

more closely matches the natural

physiological insulin response of a person

without diabetes, after meals, compared

with the current standard of care (rapidacting insulin, NovoRapid [insulin aspart]).

Fast-acting insulin aspart is being made

available to the NHS at no additional cost

versus conventional insulin aspart and may

help patients tighten the control of their

blood sugar levels after meals.

Human trials have shown that fastacting insulin aspart is absorbed faster

than insulin aspart, appearing twice as

fast in the bloodstream after injection,

which leads to improved control of blood

Last year Diabetes UK gathered the

opinions of healthcare professionals, people

with Type 2 diabetes, and their carers to

establish what their biggest concerns are

that scientists need to answer. Thousands

of ideas were submitted, after analysing all

the responses, Diabetes UK now has a list

of 114 that needs to be whittled down to

a Top 10.

Diabetes UK's Director of Research,

Dr Elizabeth Robertson, says: "We were

delighted with the numbers of responses

to our initial survey - it was one of the

largest responses that this kind of survey

has seen. But we're not finished. We now

want help to find the Top 10 priorities for

Type 2 research so that the research we

fund reflects the needs of people with

diabetes and those who care for them."

The latest survey is again open to

healthcare professionals, people with

Type 2 diabetes and their carers. Please

complete before 12 May. Call 0345-123-

2399 to receive a paper copy in the post,

or do online:

www.diabetes.org.uk/t2-top-10. INNOVATION

REWARDED

Owen Mumford has been recognised

as a winner of the Queen's Award for

Enterprise Innovation 2017. The innovation

award celebrates organisations showing

outstanding and/or sustained commercial

success over a period of years. The winners

were chosen by the Queen, on advice of

the former Prime Minister at the time, David

Cameron. The winners were announced

on the Queen's birthday. Owen Mumford

received the award in recognition of the new

innovations in medical device design the

company has developed to improve quality

of life, encourage adherence to treatment,

and reduce healthcare costs.

With a 65-year history of medical

device firsts, Owen Mumford offers

innovations in diagnostic sampling to drug

delivery from a broad base of proven selfinjection and blood sampling platform

devices and intellectual property. The

award acknowledged Owen Mumford's

developments in injection pen needles

specifically Unifine Pentips Plus.

Medical diagnostics company BHR is interested in finding out about your

understanding of what an HbA1c test is. If you would like to be entered into a prize

draw for one of five free A1CNow twin packs (worth £50 each), then leave your

email address at the end of the survey. HbA1c survey_BHR

FAST FOOD &

DIABETES

As reported in Diabetes Health,

researchers at Japan's Dokkyo Medical

University School of Medicine recently

conducted a study to see how eating

speed might affect metabolic syndrome.

The study examined nearly 9,000

community members from the ages of 40

to 75 without metabolic syndrome in 2008.

The researchers followed up wit in 2011

to see how self-reported eating speed and

the incidence of metabolic syndrome were

related. A significant relationship was found

between eating speed, HDL cholesterol,

and waist circumference. Eating slowly

could be an important lifestyle choice for

preventing metabolic syndrome among

Japanese residents.

sugar levels after meals. Fast-acting

insulin aspart significantly improves overall

control of blood sugar levels in patients

with Type 1 diabetes and had comparable

control of blood sugar levels in patients

with Type 2 diabetes, versus insulin

aspart. Control of blood sugar levels after

meals was also significantly improved in

patients with Type 1 or Type 2 diabetes at

1 hour after eating vs insulin aspart.

The diagram shows the evolution of

mealtime insulins from Novo Nordisk.

Click the pic to download as a PDF.

T2 RESEARCH PRIORITIES

Index

  1. Desang diabetes magazine diabetes information
  2. Abbott Freestyle Libre, Flash Glucose Monitoring, blood testing without lancets
  3. Desang diabetes magazine diabetes information, Sue Marshall
  4. diabetes news, novo nordisk insulin fiasp
  5. diabetes news, Medtronic, Medtronic Guardian Connect, BiAP
  6. diabetes news, Dr John Fossey, glucose
  7. Novo Nordisk diabetes mealtime management
  8. diabetes care, pocket medic, Kimberley Littlemore, Type 2 diabetes
  9. diabetes care, pocket medic, Kimberley Littlemore, Type 2 diabetes
  10. Ten Acre crisps, Jacob's Crackers
  11. A1C self check, HbA1c, Sweet Freedom
  12. Jean Cazels photography, British sandwiches, Heinz Seriously good mayo
  13. Ascensia Contour Diabetes blood test meters
  14. Accu-Chek Mobile blood glucose system
  15. Accu-Chek Mobile blood glucose system
  16. Redring tea survey, The Tea Terrace,
  17. Ecoffee, Costa Coffee
  18. Sue Marshall diabetes Professor Nick Oliver Imperial College London
  19. Professor Nick Oliver Imperial College London, BiAP, bio-inspired artificial pancreas, ABC4D, Chris
  20. Dr Philip Toleikis, Sernova, Cell Pouch technology, islet cell transplants, glucose responsive techn
  21. Dr Philip Toleikis, Sernova, Cell Pouch technology, islet cell transplants, glucose responsive techn
  22. Making Carbs Count, greek yoghurt
  23. Making Carbs Count, greek yoghurt
  24. Accu-Chek Insight insulin pump, making carbs count
  25. Accu-Chek Insight insulin pump
  26. Free diabetes magazine, Desang diabetes magazine,

Related Issues